Meanwhile, numerous dysfunctional tumor blood vessels and rapidly proliferating tumor cells create a hypoxic TME, forcing cells to upregulate the expression of glucose transporter 1 (GLUT-1) to counteract glucose consumption by tumor cells and further resulting in an acidic and hypoxic TME (58–60). The gene discussed is SLC2A1; the disease is neoplasm.